The Anti-Psoriatic Efficacy and Safety Profile of Topical and Intralesional Methotrexate: A Literature Review

References

• Nast A, Smith C, Spuls PI., et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol. 2020;34(11):2461–2498. doi:10.1111/jdv.16915
   PubMed Web of Science ®Google Scholar
• Weinstein GD. Drugs five years later: methotrexate. Ann Intern Med. 1977;86(2):199–204. doi:10.7326/0003-4819-86-2-199
   PubMed Web of Science ®Google Scholar
• Tripathi P, Kumar A, Jain PK, Patel JR. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis. Int J Biol Macromol. 2018;120(Pt A):1322–1334. doi:10.1016/j.ijbiomac.2018.08.136
   PubMed Web of Science ®Google Scholar
• Aickara D, Bashyam AM, Pichardo RO, Feldman SR. Topical methotrexate in dermatology: a review of the literature. J Dermatolog Treat. 2020;3:1–6.
   Google Scholar
• Law JH, Koo B, Koo JYM. Methotrexate update: mechanism of action in psoriasis therapy. Psoriasis Forum. 2008;14a(1):17–28. doi:10.1177/247553030814a00105
   Google Scholar
• Thomas S, Fisher K, Snowden J, Danson S, Brown S, Zeidler M. Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. Lancet. 2015;385(Suppl 1):S98. doi:10.1016/S0140-6736(15)60413-5
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Hamishehkar H. Enhancing percutaneous delivery of methotrexate using different types of surfactants. Colloids Surf B Biointerfaces. 2011;82(2):422–426. doi:10.1016/j.colsurfb.2010.09.015
   PubMed Web of Science ®Google Scholar
• Amarji B, Garg NK, Singh B, Katare OP. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics. J Drug Target. 2016;24(2):147–160. doi:10.3109/1061186X.2015.1058804
   PubMed Web of Science ®Google Scholar
• Bjerring P, Beck HI, Zachariae H, Sogaard H. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study. Acta Derm Venereol. 1986;66(6):515–519.
   PubMed Web of Science ®Google Scholar
• Eskicirak B, Zemheri E, Cerkezoglu A. The treatment of psoriasis vulgaris: 1% topical methotrexate gel. Int J Dermatol. 2006;45(8):965–969. doi:10.1111/j.1365-4632.2006.02911.x
   PubMed Web of Science ®Google Scholar
• Faghihi G, Ghafghazi T, Nilforoushzadeh MA. The effect of methotrexate 1% topical gel on psoriasis. J Isfahan Med Sch. 2012;29(173):3087–3092.
   Google Scholar
• Fry L, McMinn RM. Topical methotrexate in psoriasis. Arch Dermatol. 1967;96(5):483–488. doi:10.1001/archderm.1967.01610050005001
   PubMedGoogle Scholar
• Kumar B, Sandhu K, Kaur I. Topical 0.25% methotrexate gel in a hydrogel base for palmoplantar psoriasis. J Dermatol. 2004;31(10):798–801. doi:10.1111/j.1346-8138.2004.tb00602.x
   PubMed Web of Science ®Google Scholar
• Ravi Kumar BC, Kaur I, Kumar B. Topical methotrexate therapy in palmoplantar psoriasis. Indian J Dermatol Venereol Leprol. 1999;65(6):270–272.
   PubMedGoogle Scholar
• Stewart WD, Wallace SM, Runikis JO. Absorption and local action of methotrexate in human and mouse skin. Arch Dermatol. 1972;106(3):357–361. doi:10.1001/archderm.1972.01620120045009
   PubMedGoogle Scholar
• Sutton L, Swinehart JM, Cato A, Kaplan AS. A clinical study to determine the efficacy and safety of 1% methotrexate/Azone® (MAZ) gel applied topically once daily in patients with psoriasis vulgaris. Int J Dermatol. 2001;40(7):464–467. doi:10.1046/j.1365-4362.2001.01244.x
   PubMed Web of Science ®Google Scholar
• Syed TA, Hadi SM, Qureshi ZA, Nordstrom CG, Ali SM. Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study. J Cutan Med Surg. 2001;5(4):299–302. doi:10.1177/120347540100500403
   PubMed Web of Science ®Google Scholar
• Weinstein GD, McCullough JL, Olsen E. Topical methotrexate therapy for psoriasis. Arch Dermatol. 1989;125(2):227–230. doi:10.1001/archderm.1989.01670140079014
   PubMedGoogle Scholar
• Agrawal YO, Mahajan UB, Mahajan HS, Ojha S. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies. Int J Nanomedicine. 2020;15:4763–4778. doi:10.2147/IJN.S247007
   PubMed Web of Science ®Google Scholar
• Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2016;21(5):554–562. doi:10.3109/10837450.2015.1026605
   PubMed Web of Science ®Google Scholar
• Bahramizadeh M, Bahramizadeh M, Kiafar B, et al. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm;2019. 569. doi:10.1016/j.ijpharm.2019.05.036
   PubMed Web of Science ®Google Scholar
• Byamba D, Kim DY, Kim DS, et al. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells. Exp Dermatol. 2014;23(7):492–496. doi:10.1111/exd.12448
   PubMed Web of Science ®Google Scholar
• Chandra A, Aggarwal G, Manchanda S, Narula A. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol. 2019;7(5):362–374. doi:10.2174/2211738507666190906123643
   PubMedGoogle Scholar
• Fratoddi I, Benassi L, Botti E, et al. Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. Nanomedicine. 2019;17:276–286. doi:10.1016/j.nano.2019.01.006
   PubMed Web of Science ®Google Scholar
• Lakshmi PK, Devi GS, Bhaskaran S, Sacchidanand S. Niosomal methotrexate gel in the treatment of localized psoriasis: Phase I and Phase II studies. Indian J Dermatol Venereol Leprol. 2007;73(3):157–161. doi:10.4103/0378-6323.32709
   PubMed Web of Science ®Google Scholar
• Limón D, Talló Domínguez K, Garduño-Ramírez ML, Andrade B, Calpena AC, Pérez-García L. Nanostructured supramolecular hydrogels: towards the topical treatment of Psoriasis and other skin diseases. Colloids Surf B Biointerfaces. 2019;181:657–670. doi:10.1016/j.colsurfb.2019.06.018
   PubMed Web of Science ®Google Scholar
• Özcan A, Sahin D, Impellizzieri D, et al. Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis. J Invest Dermatol. 2020;140(5):1003–14.e8. doi:10.1016/j.jid.2019.09.018
   PubMed Web of Science ®Google Scholar
• Panonnummal R, Sabitha M. Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model. Int J Biol Macromol. 2018;110:245–258. doi:10.1016/j.ijbiomac.2017.10.112
   PubMed Web of Science ®Google Scholar
• Rajitha P, Shammika P, Aiswarya S, Gopikrishnan A, Jayakumar R, Sabitha M. Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J Drug Deliv Sci Technol. 2019;49:463–476. doi:10.1016/j.jddst.2018.12.020
   Web of Science ®Google Scholar
• Vanaja K, Rani RHS, Sacchidananda S. Formulation and clinical evaluation of ultradeformable liposomes in the topical treatment of psoriasis. Clin Res Regul Aff. 2008;25(1):41–52. doi:10.1080/10601330701885116
   Google Scholar
• Alves CO, Novaes RD, Bernardes M, et al. Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis. J Pharm Pharmacol. 2022;74(9):1342–1352. doi:10.1093/jpp/rgac006
   PubMed Web of Science ®Google Scholar
• Asad MI, Khan D, Rehman AU, Elaissari A, Ahmed N. Development and in vitro/in vivo evaluation of ph-sensitive polymeric nanoparticles loaded hydrogel for the management of psoriasis. Nanomaterials. 2021;11(12):12. doi:10.3390/nano11123433
   Web of Science ®Google Scholar
• Bernardes M, Agostini SBN, Pereira GR, et al. Preclinical study of methotrexate-based hydrogels versus surfactant based liquid crystal systems on psoriasis treatment. Eur J Pharm Sci. 2021;165:105956. doi:10.1016/j.ejps.2021.105956
   PubMed Web of Science ®Google Scholar
• Rashid SA, Bashir S, Naseem F, Farid A, Rather IA, Hakeem KR. Olive oil based methotrexate loaded topical nanoemulsion gel for the treatment of imiquimod induced psoriasis-like skin inflammation in an animal model. Biology. 2021;10:11.
   Web of Science ®Google Scholar
• Xu J, Chen H, Chu Z, et al. A multifunctional composite hydrogel as an intrinsic and extrinsic coregulator for enhanced therapeutic efficacy for psoriasis. J Nanobiotechnology. 2022;20(1):155. doi:10.1186/s12951-022-01368-y
   PubMed Web of Science ®Google Scholar
• Yang X, Tang Y, Wang M, et al. Co-delivery of methotrexate and nicotinamide by cerosomes for topical psoriasis treatment with enhanced efficacy. Int J Pharm. 2021;605:120826. doi:10.1016/j.ijpharm.2021.120826
   PubMed Web of Science ®Google Scholar
• Ali MFM, Salah M, Rafea M, Saleh N. Liposomal Methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit. 2008;14(12):I66–I74.
   Web of Science ®Google Scholar
• Andanooru Chandrappa NK, Channakeshavaiah Ravikumar B, Rangegowda SM. Iontophoretic delivery of methotrexate in the treatment of palmar psoriasis: a randomised controlled study. Australas J Dermatol. 2020;61(2):140–146. doi:10.1111/ajd.13228
   PubMed Web of Science ®Google Scholar
• Du H, Liu P, Zhu J, et al. Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019;11(46):43588–43598. doi:10.1021/acsami.9b15668
   PubMed Web of Science ®Google Scholar
• Haseena K, George S, Riyaz N, Sasidharanpillai S, Puthussery P. Methotrexate iontophoresis versus coal tar ointment in palmoplantar psoriasis: a pilot study. Indian J Dermatol Venereol Leprol. 2017;83(5):569–573. doi:10.4103/ijdvl.IJDVL_185_16
   PubMed Web of Science ®Google Scholar
• Ramez SA, Soliman MM, Fadel M, et al. Novel methotrexate soft nanocarrier/fractional erbium YAG laser combination for clinical treatment of plaque psoriasis. Artif Cells Nanomed Biotechnol. 2018;46(sup1):996–1002. doi:10.1080/21691401.2018.1440236
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Kumar BC, Udupa N, Balachandran C. Topical methotrexate delivered by iontophoresis in the treatment of recalcitrant psoriasis--A case report. Intl J Dermatol. 2003;42(2):157–159. doi:10.1046/j.1365-4362.2003.01718.x
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu S, Lu Y, et al. Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: a combined chemo-photodynamic therapy for psoriasis. Carbohydr Polym. 2022;277:118819. doi:10.1016/j.carbpol.2021.118819
   PubMed Web of Science ®Google Scholar
• Choudhary P, Mehta RD, Ghiya BC, Sharma D. Treatment of nail psoriasis with intramatrical methotrexate: an uncontrolled prospective study of 20 patients. J Am Acad Dermatol. 2021;84(2):526–528. doi:10.1016/j.jaad.2020.04.159
   PubMed Web of Science ®Google Scholar
• Duarte AA, Carneiro GP, Murari CM, Jesus LCB. Nail psoriasis treated with intralesional methotrexate infiltration. An Bras Dermatol. 2019;94(4):491–492. doi:10.1590/abd1806-4841.20198170
   PubMed Web of Science ®Google Scholar
• Grover C, Daulatabad D, Singal A. Role of nail bed methotrexate injections in isolated nail psoriasis: conventional drug via an unconventional route. Clin Exp Dermatol. 2017;42(4):420–423. doi:10.1111/ced.13087
   PubMed Web of Science ®Google Scholar
• Jindal A, Ramesh S, Noronha M, Pai K, Pai S. Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: an alternative in COVID-19. Dermatol Ther. 2020;33(4):e13787. doi:10.1111/dth.13787
   PubMed Web of Science ®Google Scholar
• Mittal J, Mahajan BB. Intramatricial injections for nail psoriasis: an open-label comparative study of triamcinolone, methotrexate, and cyclosporine. Indian J Dermatol Venereol Leprol. 2018;84(4):419–423. doi:10.4103/ijdvl.IJDVL_73_16
   PubMed Web of Science ®Google Scholar
• Mokni S, Ameur K, Ghariani N, et al. A case of nail psoriasis successfully treated with intralesional methotrexate. Dermatol Ther (Heidelb). 2018;8(4):647–651. doi:10.1007/s13555-018-0261-2
   PubMed Web of Science ®Google Scholar
• Saricaoglu H, Oz A, Turan H. Nail psoriasis successfully treated with intralesional methotrexate: case report. Dermatology. 2011;222(1):5–7. doi:10.1159/000323004
   PubMed Web of Science ®Google Scholar
• Abdelmeniem IM, El Eryan IM, Nofal A, Fouda I, Omar SS. Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: a comparative study. Dermatol Ther. 2022;35(9):e15660. doi:10.1111/dth.15660
   PubMed Web of Science ®Google Scholar
• Alakad R, Nassar A, Atef H, Eldeeb F. Fractional CO2 laser-assisted delivery versus intralesional injection of methotrexate in psoriatic nails. Dermatol Surg. 2022;48(5):539–544. doi:10.1097/DSS.0000000000003418
   PubMed Web of Science ®Google Scholar
• Starace M, Alessandrini A, Iorizzo M, et al. A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis. Clin Exp Dermatol. 2022;47(6):1165–1168. doi:10.1111/ced.15110
   PubMed Web of Science ®Google Scholar
• Haque T, Talukder MMU. Chemical enhancer: a simplistic way to modulate barrier function of the stratum corneum. Adv Pharm Bull. 2018;8(2):169–179. doi:10.15171/apb.2018.021
   PubMed Web of Science ®Google Scholar
• Songkro S. An overview of skin penetration enhancers: penetration enhancing activity, skin irritation potential and mechanism of action. Songklanakarin J Sci Technol. 2009;31(3):299–321.
   Google Scholar
• Celleno L. Topical urea in skincare: a review. Dermatol Ther. 2018;31(6):e12690. doi:10.1111/dth.12690
   PubMed Web of Science ®Google Scholar
• Kulkarni VS, Shaw C. Chapter 5 - Use of polymers and thickeners in semisolid and liquid formulations. In: Kulkarni VS, Shaw C, editors. Essential Chemistry for Formulators of Semisolid and Liquid Dosages. Boston: Academic Press; 2016:43–69.
   Google Scholar
• Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247–259. doi:10.3109/09687688.2010.522203
   PubMed Web of Science ®Google Scholar
• Pradhan M, Alexander A, Singh MR, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;107:447–463. doi:10.1016/j.biopha.2018.07.156
   PubMed Web of Science ®Google Scholar
• Carita AC, Eloy JO, Chorilli M, Lee RJ, Leonardi GR. Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr Med Chem. 2018;25(5):606–635. doi:10.2174/0929867324666171009120154
   PubMedGoogle Scholar
• Wadhwa S, Garg V, Gulati M, Kapoor B, Singh SK, Mittal N. Nanovesicles for nanomedicine: theory and practices. In: Weissig V, Elbayoumi T, editors. Pharmaceutical Nanotechnology: Basic Protocols. New York: Springer New York; 2019:1–17.
   Google Scholar
• Nayak N, Somanna P, Patil AB, Radhakrishnan A. Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal treatment of psoriasis. Ther Deliv. 2020;11(12):807–819. doi:10.4155/tde-2020-0081
   PubMed Web of Science ®Google Scholar
• Kazi KM, Mandal AS, Biswas N, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374–380. doi:10.4103/0110-5558.76435
   PubMedGoogle Scholar
• Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855. doi:10.3390/pharmaceutics12090855
   PubMed Web of Science ®Google Scholar
• Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier. J Drug Deliv Sci Technol. 2019;51:255–267. doi:10.1016/j.jddst.2019.02.017
   Web of Science ®Google Scholar
• Vincent N, Ramya DD, Vedha HB. Progress in psoriasis therapy via novel drug delivery systems. Dermatol Rep. 2014;6(1):5451. doi:10.4081/dr.2014.5451
   PubMedGoogle Scholar
• Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev. 2019;144:57–77. doi:10.1016/j.addr.2019.07.010
   PubMed Web of Science ®Google Scholar
• Venditti I. Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: a review. J King Saud Univ Sci. 2019;31(3):398–411. doi:10.1016/j.jksus.2017.10.004
   Web of Science ®Google Scholar
• Neamtu I, Rusu AG, Diaconu A, Nita LE, Chiriac AP. Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv. 2017;24(1):539–557. doi:10.1080/10717544.2016.1276232
   PubMed Web of Science ®Google Scholar
• Pavoni L, Perinelli DR, Bonacucina G, Cespi M, Palmieri GF. An overview of micro- and nanoemulsions as vehicles for essential oils: formulation, preparation and stability. Nanomaterials. 2020;10(1):1. doi:10.3390/nano10010135
   Web of Science ®Google Scholar
• Nastiti CMRR, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics. 2017;9(4):37. doi:10.3390/pharmaceutics9040037
   PubMed Web of Science ®Google Scholar
• Erdal MS, Özhan G, Mat MC, Özsoy Y, Güngör S. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations. Int J Nanomedicine. 2016;11:1027–1037. doi:10.2147/IJN.S96243
   PubMed Web of Science ®Google Scholar
• Sharma AK, Garg T, Goyal AK, Rath G. Role of microemulsions in advanced drug delivery. Artif Cells Nanomed Biotechnol. 2016;44(4):1177–1185. doi:10.3109/21691401.2015.1012261
   PubMed Web of Science ®Google Scholar
• Kale S, Deore SL. Emulsion micro emulsion and nano emulsion: a review. Sys Rev Pharm. 2016;8(1):39–47. doi:10.5530/srp.2017.1.8
   Google Scholar
• Özcan A, Bunton D, Macluskie G, Duric M, Barry J, Kolios A. Topical methotrexate gold nanoparticles reduce imiquimod-induced inflammation in mice. Br J Dermatol. 2017;177(5):e244–e5.
   Web of Science ®Google Scholar
• Rajak P, Nath L, Bhuyan B. Liquid crystals: an approach in drug delivery. Indian J Pharm Sci. 2019;81:32.
   Web of Science ®Google Scholar
• Nalone L, Marques C, Costa S, Souto EB, Severino P. Chapter 7 - Liquid crystalline drug delivery systems. In: Shegokar R, editor. Drug Delivery Trends. Elsevier; 2020:141–149.
   Google Scholar
• Wenande E, Anderson RR, Haedersdal M. Fundamentals of fractional laser-assisted drug delivery: an in-depth guide to experimental methodology and data interpretation. Adv Drug Deliv Rev. 2020;153:169–184. doi:10.1016/j.addr.2019.10.003
   PubMed Web of Science ®Google Scholar
• Lang K, Schulte KW, Ruzicka T, Fritsch C. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses. Skin Therapy Lett. 2001;6(10):1–2, 5.
   PubMedGoogle Scholar
• Shah B, Surti N, Misra A. 12 - Other routes of protein and peptide delivery: transdermal, topical, uterine, and rectal. In: Misra A, editor. Challenges in Delivery of Therapeutic Genomics and Proteomics. London: Elsevier; 2011:623–671.
   Google Scholar